Simplify Asset Management Inc. Vertex Pharmaceuticals Inc Transaction History

Simplify Asset Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$343.0 - $410.68 $1.75 Million - $2.1 Million	-5,114 Reduced 68.88%	2,311 $940,000
Q3 2023 Nov 14, 2023	SELL	$338.18 - $362.46 $22,319 - $23,922	-66 Reduced 0.88%	7,425 $2.58 Million
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $2.36 Million - $2.64 Million	7,491 New	7,491 $2.64 Million
Q4 2022 Feb 10, 2023	BUY	$285.76 - $321.48 $199,460 - $224,393	698 New	698 $201,000

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Simplify Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Simplify Asset Management Inc. with notifications on news.